Photochemical internalization: A novel technology for delivery of macromolecules into cytosol

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1180-1183

  Berg, Kristian ^a   Selbo, Pål Kristian ^a   Prasmickaite, Lina ^a   Tjelle, Torunn E ^a   Sandvig, Kirsten ^a   Moan, Johan ^a   Gaudernack, Gustav ^a   Fodstad, Øystein ^a   Kjølsrud, Siv ^a   Anholt, Helle ^a   Rodal, Gry Hege ^a   Rodal, Siv Kjersti ^a   Høgset, Anders ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; GENE THERAPY; INTERNALIZATION; NONHUMAN; PHOTOCHEMISTRY; PRIORITY JOURNAL; VACCINATION;

CYTOSOL; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; ENDOSOMES; HUMANS; LIGHT; LYSOSOMES; MACROMOLECULAR SUBSTANCES; PHOTOCHEMISTRY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0033559618     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kreitman, R. J., and Pastan, I. Immunotoxins for targeted cancer therapy. Adv. Drug Deliv. Rev., 31: 53-88, 1998.
2. Verma, I. M., and Somia, N. Gene therapy: promises, problems and prospects. Nature (Lond.), 389: 239-242, 1997.
3. Wyngaarden, J., Potts, J., Cotter, H., Martin, R. R., Mehta, V., Eckstein, F., Levin, A., Weiss, B., Black, L., Cole, R., Crooke, S., Kreig, A., and Diasio, R. Antisense '97: a roundtable on the state of the industry. Nat. Biotechnol., 15: 519-524, 1997.
4. Crooke, S. T., and Bennett, C. F. Progress in antisense oligonucleotide therapeutics. Annu. Rev. Pharmacol. Toxicol., 36: 107-129, 1996.
5. Zabner, J., Fasbender, A. J., Moninger, T., Poellinger, K. A., and Welsh, M. J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem., 270: 18997-19007, 1995.
6. Wu, M. Enhancement of immunotoxin activity using chemical and biological reagents. Br. J. Cancer. 75: 1347-1355, 1997.
7. Berg, K., and Moan, J. Lysosomes and microtubules as targets for photochemotherapy of cancer. Photochem. Photobiol., 65: 403-409, 1997.
8. Pass, H. I. Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst., 85: 443-456, 1993.
9. Moan, J., and Berg, K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol., 53: 549-553, 1991.
10. Berg, K., and Moan, J. Lysosomes as photochemical targets. Int. J. Cancer, 59: 814-822, 1994.
11. Berg, K., Maziere, J. C., Geze, M., and Santus, R. Verapamil enhances the uptake and the photocytotoxic effect of PII, but not that of tetra(4-sulfonatophenyl)porphine. Biochim. Biophys. Acta., 1370: 317-324, 1998.
12. Stirpe, F., Olsnes, S., and Pihl, A. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. J. Biol. Chem., 255, 6947-6953, 1980.
13. Barbieri, L., Battelli, M. G., and Stirpe, F. Ribosome-inactivating proteins from plants. Biochim. Biophys. Acta. 1154: 237-282, 1993.
14. Sandvig, K., Garred, O., Prydz, K., Kozlov, J. V., Hansen, S. H., and van Deurs, B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature (Lond.), 358: 510-512, 1992.
15. Berg, K., Sandvig, K., and Moan, J. Transfer of molecules into the cytosol of cells. Patent no. PCT/NO95/00149, 1996.
16. Ma, L., Moan, J., and Berg, K. Evaluation of a new photosensitizer, meso-tetrahydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int. J. Cancer. 57: 883-888, 1994.
17. Curti, B. D. Adoptive immunotherapy. Cancer Chemother. Biol. Response Modif. Annu., 17: 316-327, 1997.
18. Germain, R. N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell, 76: 287-299, 1994.
19. + T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int. J. Cancer, 72: 784-790, 1997.
20. Moan, J., Berg, K., and Kvam, E. Effects of photodynamic treatment on DNA and DNA-related cell functions. In: D. Kessel (ed.), Photodynamic Therapy of Neoplastic Disease, pp. 197-209. Boston: CRC Press, 1990.
21. Hallahan, D. E., Mauceri, H. J., Seung, L. P., Dunphy, E. J., Wayne, J. D., Hanna, N. N., Toledano, A., Hellman, S., Kufe, D. W., and Weichselbaum, R. R. Spatial and temporal control of gene therapy using ionising radiation. Nat. Med., 1: 786-791, 1995.
22. Phelan, A., Elliott, G., and O'Hare, P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol., 16: 440-443, 1998.
23. Amato, I. Cancer therapy. Hope for a magic bullet that moves at the speed of light. Science (Washington DC), 262: 32-33, 1993.
24. Sandvig, K., and Olsnes, S. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. I. Requirement for calcium. J. Biol. Chem., 257: 7495-7503, 1982.
25. Steinman, R. M., Brodie, S. E., and Cohn, Z. A. Membrane flow during pinocytosis. A stereologic analysis. J. Cell Biol., 68: 665-687, 1976.